
FDA Warning Letter to Kestra Rival Puts Global Wearable Defibrillator Market on Notice
A rival wearable cardioverter defibrillator (WCD) maker has received an FDA warning letter, according to a risk disclosure tied to Kestra Medical Technologies. The single-product US company depends on FDA clearances for its ASSURE device, and international investors are watching whether scrutiny spreads across the category.

























